ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
⏸️ Investing
Why these ASX stocks with US exposure will get a second profit tailwind
⏸️ Investing
3 top healthcare shares to buy in May
⏸️ Investing
Why the plunging Australian dollar should prompt you to look at your portfolio
⏸️ Investing
Top stock picks for May
⏸️ Investing
Tax troubles see RESMED/IDR UNRESTR shares slide
⏸️ Investing
Morgans slaps add rating on ResMed Inc. shares
⏸️ Investing
ALL ORDINARIES finishes higher Friday: 9 shares you missed
⏸️ Investing
Why these 4 ASX shares are ending the week on a high
⏸️ Investing
Is ResMed Inc a blue-chip share of tomorrow?
⏸️ Investing
5 things to watch on the ASX on Friday
⏸️ Investing
UBS & Macquarie deliver ratings on ResMed Inc. ahead of profit report
⏸️ Investing
Where I would invest $3,000 in the ASX this week
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.
